Medical weight loss

SEMAGLUTIDE

Semaglutide (Wegovy, Ozempic) is a medicine used for weight loss in specific patients, and to lower blood sugar levels. It is also used in treatment for diabetic, it helps reduce the risk of major cardiovascular events such as heart attack or stroke in type two diabetes patients. Semaglutide is a GLP-1 agonist and works by increasing insulin release, lowering the amount of glucagon released, delaying gastric emptying and reducing appetite in conjunction with diet and exercise. This is a Once a weekly injections that you can administer yourself. Treatment plan will be tailored to patient’s specific needs and goal with the best and safest options while achieving their goal.
To qualify for our weight loss program you must have a Body Mass Index Index (BMI) of greater than or equal to 30 OR a BMI of 27 with at least one weight related comorbidity such as hypertension, high cholesterol, Diabetic.

TIRZEPATIDE

Commonly known as Mounjaro this medication is FDA approved for type 2 diabetic. Given its potent weight loss properties, tirzepatide be used off-label for obesity treatment. It works as a dual GLP-1 agonist and GIP agonist to maximize similar benefits that are seen with GLP-1 medications such as semaglutide. Tirzepatide is a synthetic peptide; and a dual gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. This medication is composed of 39 amino acids. Tirzepatide stimulates insulin release from the pancreas and leads to a reduction of blood sugars (hyperglycemia). In addition, Tirzepatide also increases the levels of adiponectin. Its dual agonism id GLP-1 & GIP hormones ability leads to a more significant reduction of hyperglycemia than GLP-1 agonist agents alone and lowers the user’s appetite which causes more weight loss.

Calculate you BMI to see where you are
https://www.nhlbi.nih.gov/health/educational/lose_wt/BMI/bmicalc.htm